The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

智通财经APP获悉，美国食品和药物管理局(FDA)表示，葛兰素史克(GSK.US)和辉瑞(PFE.US)生产的一种常见呼吸道病毒疫苗必须附有警告，说明这些疫苗可能会增加一种罕见的神经系统副作用的风险，这种副作用可能导致瘫痪。该机构在周二发布的一份安全通讯中说，在呼吸道合胞病毒疫苗被批准后进行的一项研究表明，接种葛兰素史克的 ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

该机构在周二发布的一份安全通讯中说，在呼吸道合胞病毒疫苗被批准后进行的一项研究表明，接种葛兰素史克的Arexvy和辉瑞的Abrysvo的人在接种疫苗 ...

目前全球上市的RSV疫苗共有3款，分别为重组蛋白Arexvy（GSK）和Abrysvo（辉瑞），以及Moderna的mRNA疫苗mResvia，本次FDA的规定涉及前两者。 RSV属于副黏 ...

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

LONDON, GREATER LONDON, UNITED KINGDOM, January 22, 2025 /EINPresswire / -- What has been the historic growth trend in the abrysvo or arexvy global market and what is expected in the coming years?

The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...

Abrysvo and Arexvy will now be required to come with labeling that includes a warning about a potential increased risk of Guillain-Barré Syndrome. The FDA announced that it has mandated updates to the ...